ClinicalTrials.gg
Sign In

Hypoparathyroidism clinical trials

The registry lists 128 studies for Hypoparathyroidism across more than 10 countries. 30 are recruiting or about to start. 94 of them are mainly about Hypoparathyroidism (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its narrower condition DiGeorge Syndrome too: 170 studies, 41 open.

Get an email when these change. Save the Hypoparathyroidism studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
68
Recruiting
26
Status unknown
13
Terminated
6
Active, not recruiting
5
Not yet recruiting
3

Phase

Phase 2
24
Phase 3
20
Phase 1
11
Phase 4
8
Early Phase 1
3

Where

United States
43
Denmark
21
France
16
Canada
16
Italy
15
China
11

Who runs them

Shire (12) · University of Aarhus (5) · Aristotle University Of Thessaloniki (4) · Ascendis Pharma A/S (4) · Sumitomo Pharma Switzerland GmbH (3) · Entera Bio Ltd. (3) · Ascendis Pharma Bone Diseases A/S (3) · MBX Biosciences (3)

What is being tested here

Drugs under test in Hypoparathyroidism studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Palopegteriparatide245
Encaleret123
Canvuparatide112
Indocyanine Green112
Dexamethasone102
Indapamide101
Parathyroid Hormone0711
Teriparatide027
Amorphous Calcium Carbonate002
Vitamin D001

Coming up

7phase 3 studies under way
12studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 26 Hypoparathyroidism studies recruiting now, 19 (73%) set no upper age limit and 5 (19%) stop at 75 or younger. 5 (19%) take children under 18. 2 (8%) are for women only and 0 (0%) for men only; 3 (12%) take healthy volunteers.

Recruiting studies that take each age, of 26
AgeWomenMen
102 (8%)2 (8%)
1825 (96%)23 (88%)
3025 (96%)23 (88%)
4025 (96%)23 (88%)
5025 (96%)23 (88%)
6523 (88%)23 (88%)
7522 (85%)22 (85%)
8521 (81%)21 (81%)

Across all 128 studies, recruiting or not: 22% stop at 75 or younger and 13% at 65; 19% take children; 4% are for women only and 1% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hypoparathyroidism studies take

Of 15 phase 3 interventional studies under Hypoparathyroidism, half reached primary completion within 17 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 317 mo10–86 · 15 studies——
Observational23 mo7–122 · 25 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 128. Browse all 128 → or search them.